Gui Boxiang, Chen Qin, Hu Chuanxia, Zhu Caihui, He Guimei
School of Life Sciences, East China Normal University, Shanghai, 200062, People's Republic of China.
Virol J. 2017 Jan 23;14(1):10. doi: 10.1186/s12985-017-0683-y.
H9N2 influenza viruses circulate globally and are considered to have pandemic potential. The hyper-inflammatory response elicited by these viruses is thought to contribute to disease severity. Calcitriol plays an important role in modulating the immune response to viral infections. However, its unknown whether calcitriol can attenuate the inflammatory response elicited by H9N2 influenza virus infection.
Human lung A549 epithelial cells were treated with calcitriol (100 nM) and then infected with an H9N2 influenza virus, or infected and then treated with calcitriol (30 nM). Culture supernatants were collected every 24 h post infection and the viral growth kinetics and inflammatory response were evaluated. Calcitriol (5 mg/kg) was administered daily by intraperitoneal injection to BABL/c mice for 15 days following H9N2 influenza virus infection. Mice were monitored for clinical signs of disease, lung pathology and inflammatory responses.
Calcitriol treatment prior to and post infection with H9N2 influenza significantly decreased expression of the influenza M gene, IL-6, and IFN-β in A549 cells, but did not affect virus replication. In vivo, we found that calcitriol treatment significantly downregulated pulmonary inflammation in mice 2 days post-infection, but increased the inflammatory response 4 to 6 days post-infection. In contrast, the antiviral cytokine IFN-β was significantly higher in calcitriol-treated mice than in the untreated infected mice at 2 days post-infection, but lower than in untreated infected mice on days 4 and 8 post-infection. The elevated levels of pro-inflammatory cytokines and the decreased levels of antiviral cytokine are consistent with the period of maximum body weight loss and the lung damage in calcitriol-treated mice.
These results suggest that calcitriol treatment might have a negative impact on the innate immune response elicited by H9N2 infection in mice, especially at the later stage of influenza virus infection. This study will provide some novel insights into the use of calcitriol to modulate the inflammatory response elicited by influenza virus infection in humans.
H9N2流感病毒在全球传播,被认为具有大流行潜力。这些病毒引发的过度炎症反应被认为会导致疾病严重程度增加。骨化三醇在调节对病毒感染的免疫反应中起重要作用。然而,骨化三醇是否能减轻H9N2流感病毒感染引发的炎症反应尚不清楚。
用人肺A549上皮细胞用骨化三醇(100 nM)处理,然后感染H9N2流感病毒,或先感染再用骨化三醇(30 nM)处理。感染后每24小时收集培养上清液,评估病毒生长动力学和炎症反应。H9N2流感病毒感染后,每天通过腹腔注射向BABL/c小鼠给予骨化三醇(5 mg/kg),持续15天。监测小鼠的疾病临床症状、肺部病理和炎症反应。
H9N2流感病毒感染前后用骨化三醇处理显著降低了A549细胞中流感M基因、IL-6和IFN-β的表达,但不影响病毒复制。在体内,我们发现骨化三醇处理在感染后2天显著下调了小鼠肺部炎症,但在感染后4至6天增加了炎症反应。相比之下,骨化三醇处理的小鼠在感染后2天抗病毒细胞因子IFN-β显著高于未处理的感染小鼠,但在感染后第4天和第8天低于未处理的感染小鼠。促炎细胞因子水平升高和抗病毒细胞因子水平降低与骨化三醇处理小鼠体重减轻最大和肺部损伤的时期一致。
这些结果表明,骨化三醇处理可能对小鼠H9N2感染引发的先天免疫反应有负面影响,尤其是在流感病毒感染后期。本研究将为骨化三醇用于调节人类流感病毒感染引发的炎症反应提供一些新的见解。